Real-World Treatment Patterns and Effectiveness of Targeted and Immune Checkpoint Inhibitor-Based Systemic Therapy in BRAF Mutation-Positive NSCLC by Amanda J.W. Gibson, BSc (Hons), Aliyah Pabani, MD, Michelle L. Dean, BSc, Guillermo Martos, MD, Winson Y. Cheung, MD, MPH, FRCPC, Vishal Navani, M.B.B.S., MRCP, FRACP

Get full text